Researchers at Tomsk Polytechnic University in Siberia have developed what they call ?nanodrugs? based on organic synthesis to fight various cancers. Regulators are said to have given the project the green light

Siberian researchers at Tomsk Polytechnic University? Institute of High Technology Physics have developed what they call ?nanodrugs? based on organic synthesis to fight various cancers, E-News reported. It is said to be one of the most recent Russian-developed pharmaceutical compositions with targeted action. The cost of production is fairly low, the source said. ?We ?sew? on the surface of nanoparticles special proteins that stick to cancer cells and destroy them. This is the methodology we also use to make diagnostics substances employed in magnetic resonance imaging (MRI). Russia uses such drugs but doesn?t manufacture them,? said Prof. Viktor Filimonov, the head of the university?s biotechnology and organic chemistry chair and the nanodrug project leader. The Siberian scientists are closely collaborating in this effort with specialists from the Institute of Metal Physics and a sizable pharma company in the Urals. In Yekaterinburg, for example, the key components of the nanoparticles are made...